Inventiva (IVA) Divestments (2024 - 2025)
Inventiva (IVA) posted quarterly Divestments of $90.4 million for Q2 2025, up 8.23% quarter-over-quarter from $83.6 million in Q4 2024.
Inventiva (IVA) Divestments (2024 - 2025) Analysis & Trends
Inventiva's Divestments history runs 2 years deep, the most recent figure standing at $90.4 million for Q2 2025.
- In Q2 2025, Divestments changed N/A year-over-year to $90.4 million; the TTM figure through Jun 2025 stood at $90.4 million (changed N/A YoY), while the FY2024 annual figure was $83.6 million, changed N/A from the prior year.
- Divestments for Q2 2025 stood at $90.4 million, up from $83.6 million in the prior quarter.
- The five-year high for Divestments was $90.4 million in Q2 2025, with the low at $83.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 90.44 Mn |
| Dec 31, 2024 | 83.56 Mn |